Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
| (in thousands) | Six months ended March 31, 2026 | Six months ended March 31, 2025 |
|---|---|---|
| Accrued and other liabilities | 22,793 | 4,610 |
| Net cash used in operating activities | $(42,373) | $(34,414) |
| Investing activities | ||
| Purchases of property and equipment | $(17,861) | $(6,412) |
| Purchase of intangible asset | (100) | — |
| Purchases of investments | (25,227) | (25,525) |
| Proceeds from maturity of investments | 25,550 | 28,975 |
| Cash paid for asset acquisition | (5,000) | — |
Item 1. Financial Statements (unaudited)
FAQ
- What is Twist Bioscience Corporation's capex?
- Twist Bioscience Corporation (TWST) reported capex of $7.89M in Q1 2026.
- How has Twist Bioscience Corporation's capex changed year-over-year?
- Twist Bioscience Corporation's capex increased by 90.3% year-over-year, from $4.14M to $7.89M.
- What is the long-term trend for Twist Bioscience Corporation's capex?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's capex has grown at a 0.9% compound annual growth rate (CAGR), from $27.06M to $28M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Twist Bioscience Corporation's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude